ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 475360

Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.

Eriksson B and 1 other. Antimicrob Agents Chemother, 1979. Cited by 51 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate. Papers, record 475360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475360

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.42
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eriksson BB
2Oberg BB

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
HerpesviridaeMajor topic
Organophosphorus CompoundsMajor topic
Phosphonoacetic AcidMajor topic
DNA-Directed DNA Polymerase
Drug Resistance, Microbial
Formates
Idoxuridine
Mutation
Temperature
Vidarabine

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,117,474CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE.Proc Soc Exp Biol Med1964https://conductscience.org/library/papers/14117474PubMed
2206,200Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/206200PubMed
3612,702Rational design of arabinosyl nucleosides as antitumor and antiviral agents.Jpn J Antibiot1977https://conductscience.org/library/papers/612702PubMed
4210,500Trisodium phosphonoformate, a new antiviral compound.Science1978https://conductscience.org/library/papers/210500PubMed
5201,588Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.Intervirology1978https://conductscience.org/library/papers/201588PubMed
6197,275Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1.J Virol1977https://conductscience.org/library/papers/197275PubMed
721,304Nonstructural proteins of herpes simplex virus. I. Purification of the induced DNA polymerase.J Virol1977https://conductscience.org/library/papers/21304PubMed
8189,089Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.J Virol1977https://conductscience.org/library/papers/189089PubMed
9213,015Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/213015PubMed
10280,152A working hypothesis--virus resistance development as an indicator of specific antiviral activity.Ann N Y Acad Sci1977https://conductscience.org/library/papers/280152PubMed

1 to 10 of 15

See all 15 references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
21,245,660Recent advances in cloning herpesviral genomes as infectious bacterial artificial chromosomes.Cell Cycle2011https://conductscience.org/library/papers/21245660PubMed
7,527,325Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.Drugs1994https://conductscience.org/library/papers/7527325PubMed
6,328,014Cooperative effects between two acyclovir resistance loci in herpes simplex virus.J Virol1984https://conductscience.org/library/papers/6328014PubMed
6,311,091Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6311091PubMed
6,307,1319-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6307131PubMed
6,297,382Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6297382PubMed
6,289,741A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6289741PubMed
6,284,981Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.J Virol1982https://conductscience.org/library/papers/6284981PubMed
6,271,053Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6271053PubMed
6,268,019Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.Arch Virol1981https://conductscience.org/library/papers/6268019PubMed

1 to 10 of 16

See all 16 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/475360

GET https://conductscience.org/api/papers/v1/475360/authors

API referenceFor AI assistants